Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133 Xe-clearance technique

Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by... Intravenous vasopressin at 0.07 IU/min/kg decreased peritoneal blood flow as measured indirectly with the 133 Xe-clearance method. Intraperitoneal 5-FU abrogated the reduction in peritoneal blood flow with intravenous vasopressin the first day after treatment. In contrast, the presence of peritoneal carcinomatosis did not influence peritoneal blood flow, nor the effect of vasopressin http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Chemotherapy and Pharmacology Springer Journals

Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133 Xe-clearance technique

Loading next page...
 
/lp/springer-journals/effect-of-carcinomatosis-and-intraperitoneal-5-fluorouracil-on-NV0MP0zd9K

References (23)

Publisher
Springer Journals
Copyright
Copyright © 2004 by Springer-Verlag
Subject
Medicine
ISSN
0344-5704
eISSN
1432-0843
DOI
10.1007/s00280-004-0812-3
pmid
15138707
Publisher site
See Article on Publisher Site

Abstract

Intravenous vasopressin at 0.07 IU/min/kg decreased peritoneal blood flow as measured indirectly with the 133 Xe-clearance method. Intraperitoneal 5-FU abrogated the reduction in peritoneal blood flow with intravenous vasopressin the first day after treatment. In contrast, the presence of peritoneal carcinomatosis did not influence peritoneal blood flow, nor the effect of vasopressin

Journal

Cancer Chemotherapy and PharmacologySpringer Journals

Published: Sep 1, 2004

There are no references for this article.